Merck Subpoenaed By DoJ: Vioxx Investigations Under Way
This article was originally published in The Pink Sheet Daily
Executive Summary
Investigation is focusing on "research, marketing and selling activities" for Vioxx, Merck says. The Securities & Exchange Commission has also opened an "informal inquiry" into the product withdrawal.